Skip to content
Research Article Open access CC BY 4.0

Early Detection of Prostate Cancer: Immunoassay for Serum Prostate Specific Antigen (PSA) Tumor Marker

Tunji Akande

International Journal of Biochemistry Research & Review · pp. 1–8 · Published 27 Apr 2016

10.9734/IJBCRR/2016/24832

Abstract

Background: Serum tumor markers are widely used clinically for monitoring response to therapy and detecting cancer recurrence. However, only a limited number of them have been effectively used for the early detection of cancer. Objective: To review serum tumor markers used clinically, for the early detection of prostate cancer. Methods: Literature review of serum tumor marker that have been widely accepted for the early detection of prostate cancer. Results: In Nigeria only prostate specific antigen (PSA) has been clinically used for the early detection of prostate cancer. The analytical and clinical issues linked to its use were discussed. Conclusion: Few serum tumor markers have been used effectively for the early detection of cancer, mainly due to their limited diagnostic sensitivity and specificity. PSA is the only tissue-specific marker identified, but it is not specific for prostate cancer. Various approaches have been developed to improve the clinical performance of PSA for the early detection of prostate cancer.

Serum tumor marker early detection prostate cancer

Cited by 0

No indexed citations yet.

Article metrics

Real usage data collected on this platform.

0

Page views

0

PDF downloads

0

Outbound clicks

0

Citations

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

No views recorded yet.

Traffic sources

Referring site, by host.

No traffic recorded yet.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.